The National Institutes of Health (NIH) plays a vital role in funding biomedical research at universities across the country. Proposed cuts to indirect cost payments on NIH grants would severely impact the ability of universities to support research labs and operations. This move threatens to undermine America's preeminence in scientific and medical breakthroughs. As millions suffer from diseases lacking cures, sustained investment in NIH funding for basic and applied research is crucial for driving innovation and advancing public health. Cutting funds that enable groundbreaking work would be a major setback with substantial economic repercussions, as NIH funding catalyzes job creation, private sector investment, and the development of pioneering drugs, devices, and therapies that drive economic growth while improving lives.

In the wake of Trump’s unnerving appointees, the investigative journalist and veteran of the libel court offers pointers on coping in an age of surveillance